MyAverix Finance MyAverix Finance

XETRA · Healthcare

PENTIXAPHARM HOLDING N AG (PTP)

Biotechnology

PENTIXAPHARM HOLDING N AG (PTP) is listed on XETRA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for PTP

P/E ratio
25.00

PENTIXAPHARM HOLDING N AG (PTP) — FAQ

What is PTP's P/E ratio?

The price-to-earnings (P/E) ratio for PENTIXAPHARM HOLDING N AG (PTP) is 25.00 (data as of 2026-05-24).

Does PENTIXAPHARM HOLDING N AG pay a dividend?

Dividend yield is not available in the current snapshot for PENTIXAPHARM HOLDING N AG (PTP). Check the MyAverix Finance app for the latest dividend data.

What sector is PENTIXAPHARM HOLDING N AG in?

PENTIXAPHARM HOLDING N AG (PTP) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PTP listed on?

PTP is listed on XETRA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Aimed Bio (0009K0) Celltrion (068270) Rznomics (476830)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play